Suppression of cortical spreading depression in migraine prophylaxis

Topiramate, valproate, propranolol, amitriptyline, and methysergide are commonly used for migraine prevention. However, their exact action mechanisms remain uncertain. Cortical spreading depression (CSD) is linked to migraines and headache triggers. Researchers hypothesized that migraine treatments might suppress CSD as a common action. In studies, rats received migraine drugs, vehicle, or D-propranolol, a non-effective drug. The goal was to evaluate treatment effects on CSD frequency. Chronic treatment with migraine drugs reduced CSD frequency by 40% to 80%. It also increased the threshold needed to trigger CSD. Acute treatments did not show effectiveness. Longer treatment durations led to greater CSD suppression. Chronic D-propranolol treatment results were similar to saline controls. This study suggests that targeting CSD could benefit migraine treatments. Future research may explore CSD threshold assessment to improve migraine prevention strategies and drug development. Clinical relevance: This research indicates that targeting cortical spreading depression could enhance migraine prevention strategies and lead to better treatment options for patients.